Current smoking alters phospholipid- and surfactant protein A levels in small airway lining fluid: An explorative study on exhaled breath
Authors:
Open Access
- 25 June 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0253825
Abstract
Small airways are difficult to access. Exhaled droplets, also referred to as particles, provide a sample of small airway lining fluid and may reflect inflammatory responses. We aimed to explore the effect of smoking on the composition and number of exhaled particles in a smoker-enriched study population. We collected and chemically analyzed exhaled particles from 102 subjects (29 never smokers, 36 former smokers and 37 current smokers) aged 39 to 83 years (median 63). A breathing maneuver maximized the number exhaled particles, which were quantified with a particle counter. The contents of surfactant protein A and albumin in exhaled particles was quantified with immunoassays and the contents of the phospholipids dipalmitoyl- and palmitoyl-oleoyl- phosphatidylcholine with mass spectrometry. Subjects also performed spirometry and nitrogen single breath washout. Associations between smoking status and the distribution of contents in exhaled particles and particle number concentration were tested with quantile regression, after adjusting for potential confounders. Current smokers, compared to never smokers, had higher number exhaled particles and more surfactant protein A in the particles. The magnitude of the effects of current smoking varied along the distribution of each PEx-variable. Among subjects with normal lung function, phospholipid levels were elevated in current smokers, in comparison to no effect of smoking on these lipids at abnormal lung function. Smoking increased exhaled number of particles and the contents of lipids and surfactant protein A in the particles. These findings might reflect early inflammatory responses to smoking in small airway lining fluid, also when lung function is within normal limits.Keywords
Funding Information
- the Swedish Research Council for Health, Working Life and Welfare (A-CO, Grant nr:201600419)
- The Heart and Lung foundation Sweden (A-CO, Grant nr: 20180209)
- Swedish Foundation for Strategic Research, the Karolinska Institute, AstraZeneca & Science for Life Laboratory Joint Research Collaboration, and the Vårdal Foundation
This publication has 41 references indexed in Scilit:
- Influence of Film Dimensions on Film Droplet FormationJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Elevation of surfactant protein A in plasma and sputum in cigarette smokersEuropean Respiratory Journal, 2011
- Alveolar Surfactant Homeostasis and the Pathogenesis of Pulmonary DiseaseAnnual Review of Medicine, 2010
- Pulmonary Surfactant: An Immunological PerspectiveCellular Physiology and Biochemistry, 2010
- Airway Monitoring by Collection and Mass Spectrometric Analysis of Exhaled ParticlesAnalytical Chemistry, 2008
- Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung DiseaseProceedings of the American Thoracic Society, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluidEuropean Respiratory Journal, 2004
- Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers.Thorax, 1992
- The Relations between Structural Changes in Small Airways and Pulmonary-Function TestsNew England Journal of Medicine, 1978